Diagnosis and therapy of mild and moderate cognitive disorders in elderly patients with hypertonic encephalopathy

Putilina M.V.

Kafedra nevrologii fakulteta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Authors:

Putilina M.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(2): 83‑86

Downloaded: 7

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Putilina MV. Diagnosis and therapy of mild and moderate cognitive disorders in elderly patients with hypertonic encephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(2):83‑86. (In Russ.)

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)

Close metadata

Keywords:

hypertonic encephalopathy

cognitive disorders

elderly age

neuroprotective therapy

Authors:

Putilina M.V.

Kafedra nevrologii fakulteta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

List of references:

Berezina I.N. Neirofiziologicheskie mekhanizmy narusheniya kognitivnoi deyatel'nosti pri organicheskom porazhenii golovnogo mozga: Avtoref. dis. … kand. med. nauk. M 2006; 18-21.
Boiko A.N., Chugunov A.V., Kamchatnov P.R. Sosudistye kognitivnye rasstroistva – sovremennye vozmozhnosti lecheniya. Trudnyi patsient 2008; 10: 21-22.
Vereshchagin N.N. i dr. Patologiya golovnogo mozga pri ateroskleroze i arterial'noi gipertonii. Monografiya. M: Meditsina 1997; 288.
Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M: Meditsina 2000; 328.
Damulin I.V. Legkie kognitivnye narusheniya. Consilium Medicum 2004; 6: 2: 149-150.
Damulin I.V. Sosudistye kognitivnye narusheniya u pozhilykh. Rus med zhurn 2009; 17: 11: 721-725.
Zakharov V.V., Yakhno N.N. Narusheniya pamyati. M: GeotarMed 2003; 158.
Zakharov V.V., Yakhno N.N. Kognitivnye rasstroistva v pozhilom i starcheskom vozraste. Metod. posobie dlya vrachei. M 2005; 74.
Kalashnikova L.A. Kognitivnye narusheniya i dementsiya pri tserebrovaskulyarnykh zabolevaniyakh. Nervnye bolezni 2005; 2: 36-40.
Karlov A.V. Primenenie preparata kavinton forte u bol'nykh s distsikulyatornoi entsefalopatiei. RMZh 2004; 12: 10: 626-628.
Kotov S.V., Isakova E.V., Ryabtseva A.A. i dr. Kompleksnaya terapiya khronicheskoi ishemii mozga. Pod red. V.Ya. Neretina. M 2001; 5-32.
Lokshina A.B., Zakharov V.V. Legkie i umerennye kognitivnye rasstroistva pri distsirkulyatornoi entsefalopatii. Nevrol zhurn (prilozhenie 1) 2006; 11: 57-64.
Luriya A.R. Narusheniya pamyati pri lokal'nykh porazheniyakh mozga. V kn.: Neiropsikhologiya. Pod. red. E.D. Khomskoi. M: 1984: 66-74.
Odinak M.M., Amelin A.Yu., Lobzin V.Yu. Narushenie kognitivnykh funktsii pri tserebrovaskulyarnoi patologii. St-Peterburg: VMA 2006; 157.
Oshchepkova E.V. Gipertonicheskaya entsefalopatiya: vozmozhnosti profilaktiki. Spravochnik poliklinicheskogo vracha 2003; 3: 1-4.
Suslina Z.A., Tanashyan M.M. i dr. Kavinton v lechenii bol'nykh s ostrymi i khronicheskimi sosudistymi zabolevaniyami golovnogo mozga. Farmateka 2004; 14: 99-104.
Chukanova E.I., Nikonov A.A., Nikonova A.A. Novye vozmozhnosti ispol'zovaniya preparata kavinton v lechenii patsientov s nedostatochnost'yu mozgovogo krovoobrashcheniya. RMZh 2009; 17: 6: 1-7.
Yakhno N.N., Zakharov V.V. Legkie kognitivnye narusheniya v pozhilom vozraste. Nevrol zhurn 2004; 1: 4-8.
Backhauss S., Karkoutly S., Welsch M. et al. A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J Pharm Toxicol Methods 1992; 27: 27-32.
Balestreri R., Fontana L., Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriat Soc 1987; 35: 425-430.
Blaha L., Erzigkeit H., Adamczyk A. et al. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psych 1989; 4: 103-111.
George A.E., de Lean M.J., Kalnin A. et al. Leukoencephalopathy in normal and pathologic aging. II. MRI of brain lucencies. AJNR 1986; 7: 567-570.
Hindmarch L., Fuchs H.-H., Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyn-dromes. Int Clin Psych 1991; 6: 31-43.
Ishihara K., Katsuki H., Sugimura M. et al. Idebenone and vinpocetine augment long-term potentiation in hippocampal scices in the guinea pig. Neuropharm 1989; 28: 569-573.
King G.A. Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. Arch Int Pharm Ther 1987; 286: 299-307.
Krieglstein J., Rischke R. Vinpocetine increases the neuroprotective effect of adenosine in vitro. Eur J Pharm 1991; 205: 7-10.
Petersen R.S., Smith G.E., Waring S.C. et al. Practice parameter. Early detection of dementia: mild cognitive impairment. Report of Quality Standards Subcommittee of American Academy of Neurology. Neurology 2001; 56: 1133-1142.
Schubert P., Ogata T., Marchini C. et al. Protective mechanisms of adenosine in neurons and glial cells. Ann N Y Acad Sci 1997; 825: 1-10.

Close metadata